Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

(2011) A. Novotna et al.   EUROPEAN JOURNAL OF NEUROLOGY

A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)

(2011) W Notcutt et al.   Multiple Sclerosis Journal

THE EFFECT OF DANTRIUM®* ON SPASTICITY IN MULTIPLE SCLEROSIS

(2010) Herbert Ladd et al.   ACTA NEUROLOGICA SCANDINAVICA

A DOUBLE-BLIND TRIAL WITH BACLOFEN (LIORESAL®) AND DIAZEPAM IN SPASTICITY DUE TO MULTIPLE SCLEROSIS

(2010) Arne From et al.   ACTA NEUROLOGICA SCANDINAVICA

Nightly Sublingual Tizanidine HCl in Multiple Sclerosis

(2010) Veronika Vakhapova et al.   CLINICAL NEUROPHARMACOLOGY

Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity

(2010) Matthias Karst et al.   DRUGS

Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis

(2010) Derick T Wade et al.   Multiple Sclerosis Journal

Neurolytic phenol blockade of the obturator nerve for severe adductor spasticity

(2009) T. AKKAYA et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Stop using the Ashworth Scale for the assessment of spasticity

(2009) J F M Fleuren et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Quantifying repeatability of the Wartenberg pendulum test parameters in children with spasticity

(2009) Malgorzata Syczewska et al.   JOURNAL OF NEUROSCIENCE METHODS

Adverse effects of medical cannabinoids: a systematic review

(2008) T. Wang et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial

(2008) John T. Farrar et al.   CLINICAL THERAPEUTICS

Intrathecal phenol: an old treatment revisited

(2008) Colin Pinder et al.   DISABILITY AND REHABILITATION